STOCK TITAN

[Form 4] Celsius Holdings, Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Jarrod Langhans, Chief Financial Officer of Celsius Holdings, Inc. (CELH), reported an insider sale. On 08/18/2025 he disposed of 5,000 shares of CELH common stock at $60.00 per share, leaving him with 104,227 shares beneficially owned after the transaction. The filing indicates the sale was effected under a Rule 10b5-1 trading plan that the reporting person adopted on September 13, 2024. The Form 4 was signed by an attorney-in-fact on 08/19/2025. No derivative transactions or additional material details are disclosed in this filing.

Jarrod Langhans, Chief Financial Officer di Celsius Holdings, Inc. (CELH), ha comunicato una vendita da parte di insider. In data 18/08/2025 ha ceduto 5.000 azioni ordinarie CELH al prezzo di $60,00 per azione, restando titolare di 104.227 azioni a seguito dell’operazione. La documentazione indica che la vendita è stata eseguita nell’ambito di un piano di negoziazione ai sensi della Rule 10b5-1 adottato dal dichiarante il 13 settembre 2024. Il Modulo 4 è stato firmato da un procuratore il 19/08/2025. Nel deposito non sono riportate transazioni in derivati né altri dettagli materiali aggiuntivi.

Jarrod Langhans, Director Financiero (CFO) de Celsius Holdings, Inc. (CELH), informó una venta por parte de un insider. El 18/08/2025 vendió 5.000 acciones ordinarias de CELH a $60.00 por acción, quedando con 104.227 acciones en propiedad tras la transacción. La presentación indica que la venta se efectuó conforme a un plan de negociación bajo la Regla 10b5-1 que la persona informante adoptó el 13 de septiembre de 2024. El Formulario 4 fue firmado por un apoderado el 19/08/2025. En este informe no se revelan operaciones con derivados ni otros detalles materiales adicionales.

Jarrod Langhans, Celsius Holdings, Inc. (CELH) 최고재무책임자(CFO), 내부자 매도 사실을 보고했습니다. 2025-08-18에 CELH 보통주 5,000주를 주당 $60.00에 처분했으며, 거래 후 실질 보유 주식 수는 104,227주입니다. 제출서류에 따르면 해당 매도는 보고인이 2024년 9월 13일 채택한 Rule 10b5-1 거래 계획에 따라 이루어졌습니다. Form 4는 2025-08-19에 대리인에 의해 서명되었습니다. 이 신고서에는 파생상품 거래나 기타 중요한 추가 상세 내용은 기재되어 있지 않습니다.

Jarrod Langhans, directeur financier (CFO) de Celsius Holdings, Inc. (CELH), a déclaré une vente d'initié. Le 18/08/2025, il a cédé 5 000 actions ordinaires CELH au prix de 60,00 $ par action, ce qui le laisse détenteur de 104 227 actions après la transaction. Le dépôt indique que la vente a été effectuée dans le cadre d'un plan de négociation conforme à la règle 10b5-1 adopté par le déclarant le 13 septembre 2024. Le formulaire 4 a été signé par un mandataire le 19/08/2025. Aucun placement en dérivés ni autre détail matériel supplémentaire n'est divulgué dans ce dépôt.

Jarrod Langhans, Chief Financial Officer von Celsius Holdings, Inc. (CELH), meldete einen Insider-Verkauf. Am 18.08.2025 veräußerte er 5.000 Stammaktien von CELH zu je $60,00 und besitzt nach der Transaktion noch 104.227 Aktien wirtschaftlich. Die Einreichung weist aus, dass der Verkauf im Rahmen eines Rule-10b5-1-Handelsplans erfolgte, den die meldende Person am 13. September 2024 angenommen hatte. Das Formular 4 wurde am 19.08.2025 von einem Bevollmächtigten unterzeichnet. In dieser Meldung werden keine Derivatgeschäfte oder weitere wesentliche Details offengelegt.

Positive
  • Sale executed under a Rule 10b5-1 trading plan, indicating a pre-arranged, compliant transaction
  • Filing reports clear post-transaction ownership of 104,227 shares, providing transparency
Negative
  • Insider disposed of 5,000 shares, reducing beneficial ownership
  • Form 4 lacks context on proportion of total company ownership, limiting assessment of materiality

Insights

TL;DR: Routine insider sale under a pre-established trading plan; modest size relative to total holdings.

The reported sale of 5,000 shares at $60 reduces the CFO's direct stake to 104,227 shares. Because the sale was executed pursuant to a Rule 10b5-1 plan adopted in September 2024, this is a pre-arranged transaction designed to provide an affirmative defense to insider trading claims. The transaction itself does not disclose company performance metrics or indicate a change in corporate strategy, and the amount sold appears modest versus the remaining holdings reported.

TL;DR: Compliance process followed; 10b5-1 disclosure reduces regulatory concern but warrants routine monitoring.

The filing explicitly states the sale was executed under a 10b5-1 trading plan, which, if properly adopted and documented, typically mitigates regulatory scrutiny. The Form 4 includes an attorney-in-fact signature, indicating proper filing formalities. No anomalous patterns or derivative activity are reported here, so immediate compliance risk appears low based on this single filing.

Jarrod Langhans, Chief Financial Officer di Celsius Holdings, Inc. (CELH), ha comunicato una vendita da parte di insider. In data 18/08/2025 ha ceduto 5.000 azioni ordinarie CELH al prezzo di $60,00 per azione, restando titolare di 104.227 azioni a seguito dell’operazione. La documentazione indica che la vendita è stata eseguita nell’ambito di un piano di negoziazione ai sensi della Rule 10b5-1 adottato dal dichiarante il 13 settembre 2024. Il Modulo 4 è stato firmato da un procuratore il 19/08/2025. Nel deposito non sono riportate transazioni in derivati né altri dettagli materiali aggiuntivi.

Jarrod Langhans, Director Financiero (CFO) de Celsius Holdings, Inc. (CELH), informó una venta por parte de un insider. El 18/08/2025 vendió 5.000 acciones ordinarias de CELH a $60.00 por acción, quedando con 104.227 acciones en propiedad tras la transacción. La presentación indica que la venta se efectuó conforme a un plan de negociación bajo la Regla 10b5-1 que la persona informante adoptó el 13 de septiembre de 2024. El Formulario 4 fue firmado por un apoderado el 19/08/2025. En este informe no se revelan operaciones con derivados ni otros detalles materiales adicionales.

Jarrod Langhans, Celsius Holdings, Inc. (CELH) 최고재무책임자(CFO), 내부자 매도 사실을 보고했습니다. 2025-08-18에 CELH 보통주 5,000주를 주당 $60.00에 처분했으며, 거래 후 실질 보유 주식 수는 104,227주입니다. 제출서류에 따르면 해당 매도는 보고인이 2024년 9월 13일 채택한 Rule 10b5-1 거래 계획에 따라 이루어졌습니다. Form 4는 2025-08-19에 대리인에 의해 서명되었습니다. 이 신고서에는 파생상품 거래나 기타 중요한 추가 상세 내용은 기재되어 있지 않습니다.

Jarrod Langhans, directeur financier (CFO) de Celsius Holdings, Inc. (CELH), a déclaré une vente d'initié. Le 18/08/2025, il a cédé 5 000 actions ordinaires CELH au prix de 60,00 $ par action, ce qui le laisse détenteur de 104 227 actions après la transaction. Le dépôt indique que la vente a été effectuée dans le cadre d'un plan de négociation conforme à la règle 10b5-1 adopté par le déclarant le 13 septembre 2024. Le formulaire 4 a été signé par un mandataire le 19/08/2025. Aucun placement en dérivés ni autre détail matériel supplémentaire n'est divulgué dans ce dépôt.

Jarrod Langhans, Chief Financial Officer von Celsius Holdings, Inc. (CELH), meldete einen Insider-Verkauf. Am 18.08.2025 veräußerte er 5.000 Stammaktien von CELH zu je $60,00 und besitzt nach der Transaktion noch 104.227 Aktien wirtschaftlich. Die Einreichung weist aus, dass der Verkauf im Rahmen eines Rule-10b5-1-Handelsplans erfolgte, den die meldende Person am 13. September 2024 angenommen hatte. Das Formular 4 wurde am 19.08.2025 von einem Bevollmächtigten unterzeichnet. In dieser Meldung werden keine Derivatgeschäfte oder weitere wesentliche Details offengelegt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Langhans Jarrod

(Last) (First) (Middle)
2381 NW EXECUTIVE CENTER DR.

(Street)
BOCA RATON FL 33431

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Celsius Holdings, Inc. [ CELH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.001 par value per share(1) 08/18/2025 S 5,000 D $60 104,227 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2024.
Remarks:
/s/ Richard Mattessich, Attorney-in-fact 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CELH insider Jarrod Langhans report on Form 4?

The Form 4 reports that CFO Jarrod Langhans sold 5,000 shares of CELH common stock on 08/18/2025 at $60.00 per share.

Was the sale by the CELH CFO part of an approved trading plan?

Yes. The filing states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024.

How many CELH shares does Jarrod Langhans own after the transaction?

Following the reported sale, the filing shows 104,227 shares beneficially owned by the reporting person.

Who signed the Form 4 for the CELH reporting person?

The Form 4 is signed by Richard Mattessich, Attorney-in-fact on 08/19/2025.

Did the Form 4 report any derivative transactions for CELH?

No. The filing contains no reported derivative securities transactions; only a non-derivative sale of common stock is disclosed.
Celsius Hldgs Inc

NASDAQ:CELH

CELH Rankings

CELH Latest News

CELH Latest SEC Filings

CELH Stock Data

14.78B
164.59M
36.19%
66.16%
8.29%
Beverages - Non-Alcoholic
Bottled & Canned Soft Drinks & Carbonated Waters
Link
United States
BOCA RATON